PMGC HOLDINGS INC. Realized Investment Gains (Losses)
PMGC HOLDINGS INC. (ELAB) reported Realized Investment Gains (Losses) of $86.39 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2026-08-14
- PMGC HOLDINGS INC. realized investment gains (losses) for the quarter ending 2026-06-30 was $63.24K, a 33.56% decline year-over-year.
- PMGC HOLDINGS INC. realized investment gains (losses) for the quarter ending 2026-03-31 was $23.15K.
- PMGC HOLDINGS INC. realized investment gains (losses) for the quarter ending 2025-12-31 was $283.45K.
- PMGC HOLDINGS INC. realized investment gains (losses) for the quarter ending 2025-09-30 was -$25.87K.
- PMGC HOLDINGS INC. realized investment gains (losses) for fiscal 2025 was -$113.92K.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $63.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $86.39K 10-Q · filed 2026-08-14 | $369.84K derived: sum of 3 quarters · filed 2026-08-14 | $343.97K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $23.15K 10-Q · filed 2026-05-15 | $306.60K derived: sum of 2 quarters · filed 2026-05-15 | $280.73K derived: sum of 3 quarters · filed 2026-05-15 | $375.91K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $283.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $257.58K derived: sum of 2 quarters · filed 2026-03-30 | $352.76K derived: sum of 3 quarters · filed 2026-03-30 | -$113.92K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$25.87K 10-Q · filed 2025-11-14 | $69.31K derived: sum of 2 quarters · filed 2025-11-14 | -$397.37K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $95.18K 10-Q · filed 2025-08-13 | -$371.49K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | -$466.68K 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |